IP Library Granted Patent US 9,228,025
Granted Patent B2
US 9,228,025 · App. 13/695,276 · Granted Jan 5, 2016

Chicken antibodies that bind to nanoparticles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,228,025
App. No.
13/695,276
Granted
Jan 5, 2016
Kind
B2
Abstract

Antibodies and antibody fragments that selectively bind to nanoparticles are provided herein.

Claims (30)

1. An isolated chicken antibody or binding fragment thereof that specifically binds to a nanoparticle, wherein the antibody or binding fragment thereof binds specifically to at least one of: a crystalline form of TiO 2 , a diesel particulate, and an asbestos fiber.

2. The isolated chicken antibody or binding fragment of claim 1 , wherein the antibody or binding fragment thereof comprises an IgY antibody.

3. The isolated chicken antibody or binding fragment of claim 2 , wherein the nanoparticle has a diameter of about 1 nanometers to about 10,000 nanometers.

4. The isolated chicken antibody or binding fragment of claim 3 , wherein the antibody or binding fragment thereof binds specifically to an asbestos fiber.

5. An isolated antibody or binding fragment thereof that binds specifically to a nanoparticle, wherein the nanoparticle comprises at least one of: a crystalline form of TiO 2 , a diesel particulate, and an asbestos fiber, wherein the antibody or binding fragment thereof is a chicken antibody.

6. The isolated antibody or binding fragment of claim 5 , wherein the antibody or binding fragment thereof is a monoclonal antibody.

7. The isolated antibody or binding fragment of claim 5 , wherein the antibody or binding fragment thereof comprises a heavy chain chicken framework region 1 .

8. The isolated antibody or binding fragment of claim 5 , wherein the antibody or binding fragment thereof comprises a heavy chain chicken framework region 2 .

9. The isolated antibody or binding fragment of claim 5 , wherein the antibody or binding fragment thereof comprises a heavy chain chicken framework region 3 .

10. The isolated antibody or binding fragment of claim 5 , wherein the antibody or binding fragment thereof comprises a heavy chain chicken framework region 4 .

11. The isolated antibody or binding fragment of claim 5 , wherein the antibody or binding fragment thereof comprises a chicken constant domain.

12. The isolated antibody or binding fragment of claim 11 , wherein the antibody or binding fragment thereof comprises a chicken variable domain.

13. An antibody composition comprising:

at least one chicken antibody or binding fragment thereof that specifically binds to a nanoparticle, wherein the nanoparticle comprises at least one of: a crystalline form of TiO 2 , a diesel particulate, and an asbestos fiber; and

at least one compound selected from the group consisting of: an aerosolizing medium, a sprayable medium, a cross-linker, a support surface, a fiber, a foam medium, a pharmaceutically acceptable carrier, a magnetic particle, a lotion, and any combination thereof.

14. The antibody composition of claim 13 , wherein the antibody or binding fragment thereof specifically binds to an asbestos fiber.

15. The antibody composition of claim 13 , wherein the antibody or binding fragment thereof is immobilized on the support surface.

16. The antibody composition of claim 15 , wherein the support surface comprises a filter.

17. The antibody composition of claim 13 , wherein the pharmaceutically acceptable carrier is at least one of a lozenge, a candy, a chewing gum, a mouthwash, or a mouth spray.

18. A composition for targeting a nanoparticle for delivery to an immune system, the composition comprising:

at least one nanoparticle, wherein the nanoparticle comprises at least one of: a crystalline form of TiO 2 , a diesel particulate, and an asbestos fiber; and

at least one chicken antibody or binding fragment thereof that specifically binds to the at least one nanoparticle.

19. An array comprising:

a support; and

at least one chicken antibody or binding fragment thereof that binds specifically to a nanoparticle, wherein the nanoparticle comprises at least one of: a crystalline form of TiO2, a diesel particulate, and an asbestos fiber, wherein the at least one chicken antibody or fragment thereof is immobilized on the support.

20. An isolated chicken antibody or binding fragment thereof that selectively binds to a nanoparticle based upon a material of the nanoparticle, wherein the nanoparticle comprises at least one of: a crystalline form of TiO 2 , a diesel particulate, and an asbestos fiber.

21. The isolated chicken antibody of claim 20 , wherein the antibody selectively binds to carbon.

22. The isolated chicken antibody of claim 20 , wherein the antibody selectively binds to silicate.

23. An isolated chicken antibody or binding fragment thereof that specifically binds to an epitope on a nanoparticulate, wherein the nanoparticle comprises at least one of: a crystalline form of TiO 2 , a diesel particulate, and an asbestos fiber.

24. The antibody of claim 23 , wherein the larger structure has a diameter of 10 to 1,000,000,000 nm.

Assignments (4)
RELEASE OF SECURITY INTEREST IN PATENTS, RECORDED ON JANUARY 29, 2019 AT REEL 048373 FRAME 0217 Recorded Sep 22, 2025
From: CRESTLINE DIRECT FINANCE, L.P., AS COLLATERAL AGENT
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 072936/0464 →
SECURITY INTEREST Recorded Jan 29, 2019
From: EMPIRE TECHNOLOGY DEVELOPMENT LLC
To: CRESTLINE DIRECT FINANCE, L.P.
Reel/Frame 048373/0217 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2015
From: ION CORP PTY LTD
To: EMPIRE TECHNOLOGY DEVELOPMENT LLC
Reel/Frame 036571/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 15, 2015
From: MANION, MICHAEL KEONI
To: ION CORP PTY LTD.
Reel/Frame 036571/0585 →